Jakarta, 2026 — A documented account of how Erkavo sources, formulates, verifies, and archives every batch of daily mineral supplement produced at the Jakarta facility.
Jakarta, Q1 2021 — The sourcing protocol was established as the foundational document governing all ingredient procurement. Each prospective supplier is required to submit a certificate of composition covering elemental profile, granulation specification, and origin documentation.
Erkavo operates with a named-region sourcing mandate. This means each active ingredient in the daily complex carries a traceable regional origin, not a generic commodity designation. Supplier records are reviewed on a rolling twelve-month cycle, with re-qualification triggered by any change in production facility or material origin.
The Erkavo daily complex underwent twelve months of formulation calibration prior to its first commercial batch. Each ingredient ratio was evaluated against published nutritional research on energy metabolism, immune function, and physical activity support in adult men.
Calibration records document the evaluation pathway for each nutrient: the research sources consulted, the rationale for the selected concentration, and the dissolution profile data used to determine final serving composition. These records are archived at revision level and available on request.
Every Erkavo production batch is submitted to an independent laboratory for elemental concentration verification. The analysis covers all six active ingredients in the daily complex, confirming that per-serving quantities match labelling within acceptable compositional tolerance.
The laboratory operates separately from the Jakarta production facility. Results are issued as a signed batch report with the lot number, analysis date, and concentration findings per ingredient. Reports are cross-referenced against the production lot record before release approval is granted.
Following batch release, all production and verification documents are filed in the Erkavo lot record archive. Each entry carries a unique revision number, the production date, the facility batch stamp, and the signed laboratory report as an annexed document.
The archive is structured to allow traceability in both directions: from a product unit back to its source lot, and from a source material forward to all batches in which it was used. Four years of lot records are currently on file, covering every batch produced since the facility opened.
Erkavo products are nutritional food-supplements registered with the applicable local regulatory authority under food-supplement classification. Products meet compositional and labelling requirements for nutritional supplement categories.
Ingredient profiles in Erkavo supplements are selected based on published nutritional research and undergo independent batch verification for quality and labelling accuracy. Registration documents are maintained as part of the ongoing lot archive and are available for regulatory review on request.
Each active ingredient is sourced from a named supplier with documented chain-of-custody and food-grade processing confirmation.
Zinc citrate selected for bioavailability profile relative to oxide forms. Elemental concentration verified per batch via independent analysis. Lot entry includes supplier-issued certificate of composition.
Bisglycinate chelate form selected for reduced gastrointestinal interaction compared to oxide alternatives. Composition verified against dissolution profile. Sourcing accompanied by origin-region documentation.
Cholecalciferol form derived from lanolin. Concentration verified at 2000 IU per serving via independent laboratory analysis. Cold-chain specification confirmed at point of receipt.
Methylcobalamin form selected for its active metabolic role. Full traceability maintained from supplier origin to capsule fill. Lot record cross-references incoming material certificate with post-production verification report.
Selenium methionine form with organic-bound selenium profile. Elemental concentration verified by ICP analysis at independent laboratory. Supplier qualification includes origin-region documentation and granulation data sheet.
Ubiquinone form with documented solubility data submitted by supplier. Batch lot number recorded in certificate of composition. Concentration at 100 mg per serving confirmed by independent batch verification report.
Jakarta, 2022 — A set of operational standards was formalised following the second year of production. These standards define the minimum documentation requirements for each stage in the production and verification cycle, and serve as the internal audit basis for ongoing lot review.
The standards draw from published food-supplement compositional guidelines and incorporate requirements specific to the Indonesian regulatory framework for nutritional supplement categories. They are reviewed annually and updated by revision number when material changes occur.
Active ingredients are sourced from documented suppliers, with each batch accompanied by a certificate of composition. Sourcing prioritises suppliers whose facilities maintain food-grade processing standards.
Defines per-ingredient concentration tolerances and the minimum analysis coverage required in each independent verification report. Current revision: 04-B.
Governs the documentation trail from supplier shipment to production entry and post-production lot archive. Covers cold-chain break reporting and re-qualification procedures. Current revision: 03-A.
Specifies the analysis method, sample size, and report format required from the independent verification laboratory. Requires signed batch report with lot cross-reference. Current revision: 05-C.
Defines the minimum retention period for lot records (5 years), the revision numbering convention, and the indexing structure used for regulatory access. Current revision: 02-A.
Questions logged from reader and stockist correspondence, 2023–2026. Archived for reference.
Lot records, batch verification reports, and sourcing summaries are available on written request from the Jakarta facility.